• 1
    Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 1978; 24: 4069.
  • 2
    Beasley RP, Lin CC, Hwang LY, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981; 2: 11291133.
  • 3
    Hollinger FB. Hepatitis B virus. In: FieldsBN, KnipeDM, eds. Virology. New York: Raven, 1990: 21712238.
  • 4
    Sherker AH, Marion PL. Hepadnaviruses and hepatocellular carcinoma. Ann Rev Microbiol 1991; 45: 475508.
  • 5
    Ganem D, Varmus HE. The molecular biology of the Hepatitis B viruses. Ann Rev Biochem 1987; 56: 651693.
  • 6
    Twu JS, Schloemer RH. Transcriptional trans-activating function of hepatitis B virus. J Virol 1987; 61: 34483453.
  • 7
    Wollersheim M, Debelka U, Hofschneider PH. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 1988; 3: 545552.
  • 8
    Zahm P, Hofschneider PH, Koshy R. The HBV X-ORF encodes a trans-activator: a potential factor in viral hepatocarcinogenesis. Oncogene 1988; 3: 169177.
  • 9
    Caselmann WH, Meyer M, Kekulé AS, Lauer U, Hofschneider PH, Koshy R. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci U S A 1990; 87: 29702974.
  • 10
    Kekulé AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 1990; 343: 457461.
  • 11
    Hildt E, Hofschneider PH, Urban S. The role of hepatitis B virus (HBV) in the development of hepatocellular carcinoma. Semin Virol 1996; 7: 333347.
  • 12
    Yen TSB. Hepadnaviral X protein: review of recent progress. J Biomed Sci 1996; 3: 2030.
  • 13
    Cross JC, Wen P, Rutter WJ. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serin/threonin kinases. Proc Natl Acad Sci U S A 1993; 90: 80788082.
  • 14
    Natoli G, Chirillo P, Avantaggiati ML, Costanzo A, Ianni A, Demarzio E, Puri, P. et al. Activation of the transcription factor C-Jun/Ap 1 by the hepatitis-B virus transactivator Px occurs through a Ras-dependent and Raf-dependent signaling pathway. J Cell Biochem 1994; S18C: 215215.
  • 15
    Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A 1994; 91: 1035010354.
  • 16
    Kekulé AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signaling pathway. Nature 1993; 361: 742745.
  • 17
    Cheong JH, Yi MK, Lin Y, Murakami S. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J 1995; 14: 143150.
  • 18
    Qadri I, Maguire HE, Siddiqui A. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci USA 1995; 92: 10031007.
  • 19
    Fischer M, Runkel L, Schaller H. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit. Virus Genomes 1995; 10: 99102.
  • 20
    Lee TH, Elledge SJ, Butel JS. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol 1995; 69: 11071114.
  • 21
    Klein R, Schröder CH, Zentgraf H. Expression of the X protein of hepatitis B virus in insect cells using recombinant baculoviruses. Virus Genes 1991; 5: 157174.
  • 22
    Spandau DF, Wang HGH, Fraser M, Lee CH. A functional hepatitis B virus X protein produced in insect cells. Virology 1991; 185: 938941.
  • 23
    Schek N, Bartenschlager R, Kuhn C, Schaller H. Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene 1991; 6: 17351744.
  • 24
    Sirma H, Rosmorduc O, Urban S, Kremsdorf D, Bréchot C. Cytoplasm is the prime compartment of hepatitis B virus X protein where it associates selectively with proteasomes. Mol Cell Biol 1997; (submitted).
  • 25
    Poussin K, Schirmacher P, Urban S, Beaugrand M, Dienes H, Bréchot C, Paterlini P. Hepatitis B Virus X gene is structurally modified and expressed in hepatocellular carcinomas. Cancer Research 1997; (submitted).
  • 26
    Will H, Cattaneo R, Darai G, Deinhard F, Schellekens H, Schaller H. Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A 1985; 82: 891895.
  • 27
    O'Reilly DR, Miller LK, Luckow VA. Baculovirus Expression Vectors: A Laboratory Manual. New York: W. H. Freeman and Company, 1992.
  • 28
    Summers M D, Smith GE. A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedure. College Station: Texas A & M Bulletin, 1994.
  • 29
    Dignam JP, LeBovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res 1983; 11: 14751489.
  • 30
    Schägger H, v. Jagow G. Tricine-sodium dodecyl sulfate polyacrylamide gel electrophoresis for the separation of proteins in the range from 1–100 kDa. Anal Biochem 1987; 166: 368379.
  • 31
    Heukeshoven J, Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 1985; 6: 103112.
  • 32
    Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbour: CSH Press, 1989.
  • 33
    Hildt E, Urban S, Lauer U, Hofschneider PH, Kekulé AS. ER-localization and functional expression of the HBV transactivator MHBst. Oncogene 1993; 8: 33593367.
  • 34
    Urban S, Hildt E. Use of Ni-NTA resin for isolation of cellular proteins binding to HBV transactivator proteins HBx and MHBst. Qiagen News 1994; 1: 1416.
  • 35
    Hildt E, Urban S, Eckerskorn C, Hofschneider PH. Isolation of highly purified, functional carboxy-terminally truncated hepatitis B virus middle surface protein activators from eucaryotic expression systems. Hepatology 1996; 24: 502507.
  • 36
    Kwee L, Lucito R, Aufiero B, Schneider RJ. Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J Virol 1992; 66 (7): 43824389.
  • 37
    Doria M, Klein N, Lucito R, Schneider RJ. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of ras and nuclear activator of transcription factors. EMBO J 1995; 14: 47474757.
  • 38
    Gupta A, Mai TK, Jayasuryan N, Chauhan VS. Assignment of disulfide bonds in the X protein (HBx) of hepatitis B virus. Biochem Biophys Res Comm 1995; 212: 919924.
  • 39
    Koken SE, Greijer AE, Verhoef K, van Wamel J, Bukrinskaya AG, Berkhout B. Intracellular analysis of in vitro modified HIV Tat protein. J Biol Chem 1994; 269: 83668375.
  • 40
    Arii M, Takada S, Koike K. Identification of three essential regions of Hepatitis B virus X protein for transactivation function. Oncogene 1992; 7: 397403.
  • 41
    Siddiqui A, Jameel S, Mapoles J. Expression of the hepatitis B virus X gene in mammalian cells. Proc Natl Acad Sci U S A 1987; 84: 25132517.
  • 42
    Levrero M, Jean-Jean O, Balsano C, Will H, Perricaudett M. Hepatitis B virus (HBV) X gene expression in human cells and anti-HBx antibodies detected in chronic HBV infection. Virology 1990; 174: 299304.